Mobile-Menu

Wuxi STA to Acquire Bristol Myers Squibb’s Manufacturing Unit in Switzerland

Bristol Myers Squibb and Wuxi STA anticipate completing the transaction by Q2 2021, subject to regulatory approvals and the satisfaction of other closing conditions. (Bristol Myers Squibb) Image Zoom
Bristol Myers Squibb and Wuxi STA anticipate completing the transaction by Q2 2021, subject to regulatory approvals and the satisfaction of other closing conditions. (Bristol Myers Squibb)
1/1
Back to the Article